リベロセラ株式会社
3 known investors
LiberoThera is a drug discovery company using cell-free membrane protein preparation technology and non-natural amino acid incorporation technology to develop antibody-based therapeutics, including antibodies targeting GPCRs such as anti-CCR8. It operates through research alliances and partnerships in the biopharmaceutical field.
Investors · 3
In the news
Frequently asked questions
- What does リベロセラ株式会社 do?
- LiberoThera is a drug discovery company using cell-free membrane protein preparation technology and non-natural amino acid incorporation technology to develop antibody-based therapeutics, including antibodies targeting GPCRs such as anti-CCR8. It operates through research alliances and partnerships in the biopharmaceutical field.
- Who are リベロセラ株式会社's investors?
- リベロセラ株式会社's investors include MC Healthcare Ventures, Taiho Ventures, LLC, UTokyo Innovation Platform Co. Ltd..